Evogene Ltd.EVGNNASDAQ
Loading
Free Cash Flow Growth Under PressureDecelerating
Percentile Rank5
Year-over-Year Change
Year-over-year free cash flow growth rate
Percentile
P5
Near historical low
vs 2Y Ago
-5x
Contraction
Streak
1 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q3 2025 | -65.08% |
| Q2 2025 | 56.58% |
| Q1 2025 | 4.07% |
| Q4 2024 | -9.27% |
| Q3 2024 | 7.77% |
| Q2 2024 | -29.05% |
| Q1 2024 | 25.96% |
| Q4 2023 | -26.67% |
| Q3 2023 | 13.08% |
| Q2 2023 | 21.02% |
| Q1 2023 | -168.85% |
| Q4 2022 | 66.27% |
| Q3 2022 | -4.57% |
| Q2 2022 | 14.55% |
| Q1 2022 | 2.31% |
| Q4 2021 | -39.27% |
| Q3 2021 | 5.80% |
| Q2 2021 | -30.52% |
| Q1 2021 | 30.14% |
| Q4 2020 | -53.07% |
| Q3 2020 | -57.16% |
| Q2 2020 | 49.73% |
| Q1 2020 | -16.74% |
| Q4 2019 | -27.02% |
| Q3 2019 | 2.63% |
| Q2 2019 | 26.59% |
| Q1 2019 | -77.52% |
| Q4 2018 | 25.19% |
| Q3 2018 | -11.97% |
| Q2 2018 | 26.53% |
| Q1 2018 | -34.09% |
| Q4 2017 | -4.24% |
| Q3 2017 | 14.74% |
| Q2 2017 | 17.46% |
| Q1 2017 | -16.96% |
| Q4 2016 | -28.27% |
| Q3 2016 | -43.01% |
| Q2 2016 | 3.16% |
| Q1 2016 | 51.54% |
| Q4 2015 | -58.99% |